Author Archive

Katherine J. Wu

Staff Writer, The Atlantic

Katherine J. Wu is a staff writer at The Atlantic, where she covers science.
Katherine J. Wu is a staff writer at The Atlantic, where she covers science.
Management

Will Omicron Leave Most of Us Immune?

The variant is spreading widely, but won’t necessarily give us strong protection from new infections.

Management

Calling Omicron ‘Mild’ Is Wishful Thinking

We are far past the point of hoping that this variant will spare us.

Workforce

America’s COVID Rules Are a Dumpster Fire

If you’re confused by the CDC’s new isolation guidelines, you’re not the only one.

Workforce

Our Relationship With COVID Vaccines Is Just Getting Started

We probably will need additional shots. But just how many depends on our immune systems, the virus, and how often they collide.

Workforce

How Long Does Omicron Take to Make You Sick?

The new variant seems to be our quickest one yet. That makes it harder to catch with the tests we have.

Management

Fully Vaccinated Is About to Mean Something Else

The CDC might update the definition very soon, even though we still don’t know for sure how many shots we’ll need.

Management

Our First Preview of How Vaccines Will Fare Against Omicron

The variant will change the risk landscape for the vaccinated. The question is, how much?

Workforce

Why Are We Still Isolating Vaccinated People for 10 Days?

If vaccination people are less likely to transmit the virus, maybe they should be able to test out of isolation.

Management

Omicron Won’t Ruin Your Booster

Sometimes, dips in immunization quality can be rescued with a little extra quantity.

Management

What Makes a Vaccine’s Protection Last?

A vaccine’s value isn’t just in its peak performance; also essential to know is when, and how quickly, protection might start to decline.

Management

Five Big Questions About COVID Vaccines for Kids

With FDA authorization for a kid-size COVID vaccine pending, a pediatrician and infectious-disease expert weighs in on what’s next.

Management

Timing Is Everything for Merck’s COVID Pill

The drug, molnupiravir, is named after Thor’s hammer, Mjölnir. But its power depends on reaching the right people, in the right time frame.

Management

We Need a Better Way to Talk About Booster Shots

The phrase took off earlier this year but flew too close to the sun. Maybe we should let it burn.

Management

CDC Director: ‘Walk, Don’t Run’ to Get Your Booster

While some Pfizer recipients can now get an extra shot, federal officials are still mum on what’s next for the at-risk individuals who got Moderna or J&J.

Management

Sorry, a Coronavirus Infection Might Not Be Enough to Protect You

Anyone who’d rather have COVID-19 than get vaccinated is taking two gambles: that immunity will stick around, and that symptoms won’t.

Management

We’re Asking the Impossible of Vaccines

Complete protection against infection has long been hailed as the holy grail of vaccination. It might simply be unachievable.

Management

The Wrong Way to Test Yourself for the Coronavirus

Rapid tests can help you stay safe in the Delta outbreak. But you have to use them correctly.

Management

Delta Is Bad News for Kids

More children are falling ill because more are being infected.